313 related articles for article (PubMed ID: 17384445)
1. Upregulation of KCNE1 induces QT interval prolongation in patients with chronic heart failure.
Watanabe E; Yasui K; Kamiya K; Yamaguchi T; Sakuma I; Honjo H; Ozaki Y; Morimoto S; Hishida H; Kodama I
Circ J; 2007 Apr; 71(4):471-8. PubMed ID: 17384445
[TBL] [Abstract][Full Text] [Related]
2. KCNE2 is colocalized with KCNQ1 and KCNE1 in cardiac myocytes and may function as a negative modulator of I(Ks) current amplitude in the heart.
Wu DM; Jiang M; Zhang M; Liu XS; Korolkova YV; Tseng GN
Heart Rhythm; 2006 Dec; 3(12):1469-80. PubMed ID: 17161791
[TBL] [Abstract][Full Text] [Related]
3. Dysfunctional potassium channel subunit interaction as a novel mechanism of long QT syndrome.
Hoosien M; Ahearn ME; Myerburg RJ; Pham TV; Miller TE; Smets MJ; Baumbach-Reardon L; Young ML; Farooq A; Bishopric NH
Heart Rhythm; 2013 May; 10(5):728-37. PubMed ID: 23291057
[TBL] [Abstract][Full Text] [Related]
4. N- and C-terminal KCNE1 mutations cause distinct phenotypes of long QT syndrome.
Ohno S; Zankov DP; Yoshida H; Tsuji K; Makiyama T; Itoh H; Akao M; Hancox JC; Kita T; Horie M
Heart Rhythm; 2007 Mar; 4(3):332-40. PubMed ID: 17341399
[TBL] [Abstract][Full Text] [Related]
5. Ginsenoside Rg3 activates human KCNQ1 K+ channel currents through interacting with the K318 and V319 residues: a role of KCNE1 subunit.
Choi SH; Shin TJ; Lee BH; Chu DH; Choe H; Pyo MK; Hwang SH; Kim BR; Lee SM; Lee JH; Kim DH; Kim HC; Rhim HW; Nah SY
Eur J Pharmacol; 2010 Jul; 637(1-3):138-47. PubMed ID: 20399767
[TBL] [Abstract][Full Text] [Related]
6. Expression and coassociation of ERG1, KCNQ1, and KCNE1 potassium channel proteins in horse heart.
Finley MR; Li Y; Hua F; Lillich J; Mitchell KE; Ganta S; Gilmour RF; Freeman LC
Am J Physiol Heart Circ Physiol; 2002 Jul; 283(1):H126-38. PubMed ID: 12063283
[TBL] [Abstract][Full Text] [Related]
7. Transcripts of Kv7.1 and MinK channels and slow delayed rectifier K
Abramochkin DV; Hassinen M; Vornanen M
Pflugers Arch; 2018 Dec; 470(12):1753-1764. PubMed ID: 30116893
[TBL] [Abstract][Full Text] [Related]
8. Interaction between the cardiac rapidly (IKr) and slowly (IKs) activating delayed rectifier potassium channels revealed by low K+-induced hERG endocytic degradation.
Guo J; Wang T; Yang T; Xu J; Li W; Fridman MD; Fisher JT; Zhang S
J Biol Chem; 2011 Oct; 286(40):34664-74. PubMed ID: 21844197
[TBL] [Abstract][Full Text] [Related]
9. Adult Ventricular Myocytes Segregate KCNQ1 and KCNE1 to Keep the
Jiang M; Wang Y; Tseng GN
Circ Arrhythm Electrophysiol; 2017 Jun; 10(6):. PubMed ID: 28611207
[TBL] [Abstract][Full Text] [Related]
10. Insights into Cardiac IKs (KCNQ1/KCNE1) Channels Regulation.
Wu X; Larsson HP
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33322401
[TBL] [Abstract][Full Text] [Related]
11. 4,4'-Diisothiocyanato-2,2'-Stilbenedisulfonic Acid (DIDS) Modulates the Activity of KCNQ1/KCNE1 Channels by an Interaction with the Central Pore Region.
Bollmann E; Schreiber JA; Ritter N; Peischard S; Ho HT; Wünsch B; Strünker T; Meuth S; Budde T; Strutz-Seebohm N; Seebohm G
Cell Physiol Biochem; 2020 Apr; 54(2):321-332. PubMed ID: 32259418
[TBL] [Abstract][Full Text] [Related]
12. Chronic probucol treatment decreases the slow component of the delayed-rectifier potassium current in CHO cells transfected with KCNQ1 and KCNE1: a novel mechanism of QT prolongation.
Taniguchi T; Uesugi M; Arai T; Yoshinaga T; Miyamoto N; Sawada K
J Cardiovasc Pharmacol; 2012 Apr; 59(4):377-86. PubMed ID: 22189896
[TBL] [Abstract][Full Text] [Related]
13. The selective estrogen receptor modulator raloxifene inhibits cardiac delayed rectifier potassium currents and voltage-gated sodium current without QTc interval prolongation.
Liu H; Yang L; Jin MW; Sun HY; Huang Y; Li GR
Pharmacol Res; 2010 Nov; 62(5):384-90. PubMed ID: 20674746
[TBL] [Abstract][Full Text] [Related]
14. Long QT syndrome-associated mutations in KCNQ1 and KCNE1 subunits disrupt normal endosomal recycling of IKs channels.
Seebohm G; Strutz-Seebohm N; Ureche ON; Henrion U; Baltaev R; Mack AF; Korniychuk G; Steinke K; Tapken D; Pfeufer A; Kääb S; Bucci C; Attali B; Merot J; Tavare JM; Hoppe UC; Sanguinetti MC; Lang F
Circ Res; 2008 Dec; 103(12):1451-7. PubMed ID: 19008479
[TBL] [Abstract][Full Text] [Related]
15. Coordinated down-regulation of KCNQ1 and KCNE1 expression contributes to reduction of I(Ks) in canine hypertrophied hearts.
Ramakers C; Vos MA; Doevendans PA; Schoenmakers M; Wu YS; Scicchitano S; Iodice A; Thomas GP; Antzelevitch C; Dumaine R
Cardiovasc Res; 2003 Feb; 57(2):486-96. PubMed ID: 12566121
[TBL] [Abstract][Full Text] [Related]
16. Acute alteration of cardiac ECG, action potential, I(Kr) and the human ether-a-go-go-related gene (hERG) K+ channel by PCB 126 and PCB 77.
Park MH; Park WS; Jo SH
Toxicol Appl Pharmacol; 2012 Jul; 262(1):60-9. PubMed ID: 22676973
[TBL] [Abstract][Full Text] [Related]
17. Functional interactions between KCNE1 C-terminus and the KCNQ1 channel.
Chen J; Zheng R; Melman YF; McDonald TV
PLoS One; 2009; 4(4):e5143. PubMed ID: 19340287
[TBL] [Abstract][Full Text] [Related]
18. Action potential clamp and mefloquine sensitivity of recombinant 'I KS' channels incorporating the V307L KCNQ1 mutation.
El Harchi A; McPate MJ; Zhang YH; Zhang H; Hancox JC
J Physiol Pharmacol; 2010 Apr; 61(2):123-31. PubMed ID: 20436212
[TBL] [Abstract][Full Text] [Related]
19. Association of KCNQ1, KCNE1, KCNH2 and SCN5A polymorphisms with QTc interval length in a healthy population.
Gouas L; Nicaud V; Berthet M; Forhan A; Tiret L; Balkau B; Guicheney P;
Eur J Hum Genet; 2005 Nov; 13(11):1213-22. PubMed ID: 16132053
[TBL] [Abstract][Full Text] [Related]
20. Prolongation of cardiac ventricular repolarization under paliperidone: how and how much?
Vigneault P; Kaddar N; Bourgault S; Caillier B; Pilote S; Patoine D; Simard C; Drolet B
J Cardiovasc Pharmacol; 2011 Jun; 57(6):690-5. PubMed ID: 21394035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
